导师介绍
吕朝相，博士，副研究员，硕士生导师，党支部书记。长期从事抗肿瘤与抗病毒的分子机制研究，重点关注肿瘤细胞生物学行为调控、病毒与宿主相互作用及其在疾病发生发展中的角色。主持四川省科技厅面上项目等多项课题，参与国家重点研发计划等项目。以第一作者或通讯作者身份在Cell Mol Biol Lett、Phytomedicine等国际主流学术期刊发表论文近30篇。
研究方向
1. 肿瘤细胞生物学
2. 病毒与宿主互作
科研项目
1. 2024.01-2025.12，四川省自然科学基金面上项目。
2. 2023.07-2026.06，泸州市科技局项目。
代表性论文（#为并列第一作者，*为通讯作者）
1 Lv C, Luo N, Wei C, Zhang Q, Guo K, Jiang X, Cao X, Mazaher M, ElFar A, Fu J. DDX17-mediated raptor-dependent mTORC1 activation links autophagy inhibition and metabolic compensation in HCC development. Cell Mol Biol Lett. 2026 Apr 22. (IF = 10.7)
2 Lv C, ElFar A, Cao X, Zhang Q, Zhou P, Wang K, Liu X, Lei B, Wei C, Mei Z, Yang C, Tang K, Chinese authentic herbal medicine Ganhuangcao from Southwest China mitigates influenza virus infection by inhibiting the host JAK2/STAT1 signaling pathway, Phytomedicine, 2026, 158163. (IF = 8.3)
3 Lv C, Li Y, Wang T, Zhang Q, Qi J, Sima M, Li E, Qin T, Shi Z, Li F, Wang X, Sun W, Feng N, Yang S, Xia X, Jin N, Zhou Y, Gao Y. Taurolidine improved protection against highly pathogenetic avian influenza H5N1 virus lethal-infection in mouse model by regulating the NF-κB signaling pathway. Virol Sin. 2023 Feb;38(1):119-127. (IF = 7.0)
4 Lv C, Guo J, Luo R, Li Y, Qian B, Zou X, Wang T, Shen B, Sun W, Gao Y. Taurolidine inhibits influenza virus infection and prevents influenza-induced cytokine storm, vasoconstriction and lung damage. Cell Mol Life Sci. 2025 May 15;82(1):201. (IF = 6.2)
5 Lv C, Qu H, Zhu W, Xu K, Xu A, Jia B, Qing Y, Li H, Wei HJ, Zhao HY. Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells. Front Pharmacol. 2017 May 4; 8:244. (IF = 4.4)
6 Luo N, Mei Z, Zhang Q, Tang H, Wan R, Deng A, Zou X, Lv C*. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer. Aging (Albany NY). 2023 Dec 21;15(24):15064-15083. (IF = 5.2)
7 Zhang Q, Zhang J, Lan T, He J, Lei B, Wang H, Mei Z, Lv C*. Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy. Eur J Med Res. 2024 Mar 25;29(1):195. (IF = 4.2)
8 Cao X, Luo N, Liu X, Guo K, Deng M, Lv C*. Crosstalk of SPINK4 Expression with Patient Mortality, Immunotherapy and Metastasis in Pan-Cancer Based on Integrated Multi-Omics Analyses. Onco Targets Ther. 2025 Feb 4; 18:161-177. (IF = 2.8)
9 Sima M, Lv C#, Qi J, Guo J, Luo R, Deng X, Li Y, Wang T, Yue D, Gao Y. Anti-inflammatory effects of theaflavin-3'-gallate during influenza virus infection through regulating the TLR4/MAPK/p38 pathway. Eur J Pharmacol. 2023 Jan 5; 938:175332. (IF = 5.8)
10 Luo R, Lv C#, Wang T, Deng X, Sima M, Guo J, Qi J, Sun W, Shen B, Li Y, Yue D, Gao Y. A potential Chinese medicine monomer against influenza A virus and influenza B virus: isoquercitrin. Chin Med. 2023 Nov 2;18(1):144. (IF = 5.2)
联系方式
西南医科大学城北校区科技大楼九楼
E-mail：lvchaoxiang@126.com；lvchaoxiang@swmu.edu.cn
